Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience

Khalil Choucair,Seth J Page,Bassam I Mattar, Christopher S Dakhil,Nassim H Nabbout,Jeremy M Deutsch,Quoc V Truong,Phu V Truong,Dennis F Moore,Michael W Cannon,K James Kallail,Joseph A Moore,Shaker R Dakhil, Radwan Diab,Syed Kamran,Pavan S Reddy

Clinical Breast Cancer（2023）

引用 0|浏览2

暂无评分

摘要

Genomic testing for patients with grade 1 tumors may be safely omitted, irrespective of size. Our finds call for a better understanding of the need for routine genomic testing in patients with low grade/low clinical risk of recurrence.

查看译文

关键词

Prognostic biomarkers,Genomic-risk stratification,Adjuvant chemotherapy,Clinical risk,Clinicopathologic data

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要